| Accession |
PRJCA011352 |
| Title |
Nucleotide Biomarker Data in Orally Administered Ivosidenib Study in Chinese Subjects with Relapsed or Refractory Acute Myeloid Leukemia with an IDH1 Mutation |
| Relevance |
Medical |
| Data types |
Biomarker
|
| Organisms |
Homo sapiens
|
| Description |
A Phase 1, Multicenter, Single-Arm Study Evaluating Pharmacokinetic, Pharmacodynamic, Safety, and Clinical Efficacy of Orally Administered Ivosidenib in Chinese Subjects with Relapsed or Refractory Acute Myeloid Leukemia with an IDH1 Mutation |
| Sample scope |
Multispecies |
| Release date |
2022-08-27 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
Jingjing
Jin (jinjingjing@ihcams.ac.cn)
|
| Organization |
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences |
| Submission date |
2022-08-22 |
